What it's for (Indications)
- Dequalinium chloride is indicated for the local antiseptic treatment of various mild to moderate infections and inflammatory conditions affecting the oral cavity and pharynx.
- These indications primarily include symptomatic relief and adjunctive therapy for conditions such as pharyngitis (sore throat), laryngitis, stomatitis (inflammation of the mouth lining), gingivitis (inflammation of the gums), and aphthous ulcers.
- It is also utilized as a topical antiseptic in cases of oral thrush (candidiasis) and as an adjunct in the treatment of tonsillitis and other inflammatory conditions where local microbial reduction is beneficial.
- Its broad-spectrum antimicrobial activity against common oral pathogens, including both Gram-positive and Gram-negative bacteria, and certain fungi, makes it suitable for managing superficial infections and preventing secondary bacterial superinfections in compromised oral mucosa.
- The use is strictly for local application to the affected mucosal surfaces.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For adults and adolescents typically aged 12 years and older, the standard dosage of dequalinium chloride, when administered as an oral lozenge (e.g., Solophar Oral), is usually one lozenge dissolved slowly in the mouth every two to three hours. It is crucial to allow the lozenge to dissolve completely without chewing or swallowing it whole to maximize local contact and therapeutic effect on the oral and pharyngeal mucosa. The maximum daily dose generally should not exceed 6 to 8 lozenges within a 24-hour period. For oral sprays or solutions, the dosage regimen involves several sprays or gargles administered multiple times daily, typically 3 to 5 times a day, depending on the specific product formulation and concentration. Treatment duration should generally not exceed 5-7 days unless specifically directed by a healthcare professional, to prevent potential alteration of the normal oral flora or masking of more serious underlying conditions. Patients should always refer to the specific product's labeling for precise dosage instructions relevant to the concentration and formulation being used, and consult a healthcare professional if symptoms persist or worsen. |
Safety & Warnings
Common Side Effects
- Dequalinium chloride is generally well-tolerated when used topically in the oral cavity and pharynx.
- However, as with all medications, it can cause side effects.
- The most commonly reported adverse reactions are local in nature and include irritation of the oral or pharyngeal mucosa, such as a mild burning sensation, stinging, or dryness at the application site.
- Some individuals may experience taste disturbances, including an altered sense of taste (dysgeusia) or a temporary metallic or bitter taste, which usually resolves upon discontinuation of the medication.
- Hypersensitivity reactions, although rare, can occur and may manifest as skin rash, itching (pruritus), urticaria, or localized swelling of the face, lips, or tongue (angioedema).
- In very rare instances, more severe systemic allergic reactions may occur.
- Prolonged use or overuse of dequalinium chloride may lead to disruption of the normal oral microbial flora, potentially predisposing to fungal superinfections (e.
- g.
- , oral candidiasis) or the emergence of bacterial resistance.
- Should any adverse reaction occur, particularly signs of an allergic reaction or worsening irritation, immediate discontinuation of the product and consultation with a healthcare professional are advised for appropriate management.
Serious Warnings
- Black Box Warning: Serious Warnings: While dequalinium chloride is generally considered safe and well-tolerated for its indicated local antiseptic uses, healthcare professionals and patients must be aware of potential serious adverse events. There is no formal FDA Black Box Warning for dequalinium chloride; however, significant safety considerations warrant attention. Hypersensitivity reactions, though uncommon, can occur and may manifest as severe allergic responses including angioedema, urticaria, bronchospasm, or, in very rare instances, anaphylaxis. Immediate discontinuation of the product and appropriate medical intervention are required if such severe reactions manifest. Prolonged or excessive use of dequalinium chloride-containing products may disrupt the normal commensal flora of the oral cavity and pharynx, potentially leading to superinfection with opportunistic or resistant microorganisms, including fungi (e.g., Candida). Patients experiencing persistent or worsening symptoms beyond a few days of treatment should seek prompt medical evaluation to rule out more serious underlying infections or conditions that require systemic antimicrobial therapy or alternative treatments. This medication is strictly for local, superficial antiseptic action and should not be used for deep or extensive wounds or ingested in large quantities due to potential for significant gastrointestinal upset, irritation, or other adverse effects from systemic exposure. Keep all dequalinium chloride products, especially lozenges, out of reach of children to prevent accidental ingestion or choking hazards.
- Patients should be advised that dequalinium chloride is intended for local, superficial antiseptic treatment only and should not be used for deep or extensive wounds without specific medical advice.
- Individuals with known hypersensitivity to dequalinium chloride, other quaternary ammonium compounds, or any excipients in the formulation should avoid its use.
- If symptoms of oral or pharyngeal infection persist or worsen after several days of treatment (typically 5-7 days), or if fever, severe pain, or difficulty swallowing develops, patients should seek immediate medical attention, as these may indicate a more serious underlying condition requiring systemic therapy.
- Prolonged or excessive use can alter the normal microbial flora of the oral cavity, potentially leading to superinfection with resistant bacteria or fungi, such as Candida.
- Care should be taken to avoid contact with the eyes; in case of accidental contact, rinse thoroughly with water.
- Pregnant and breastfeeding women should consult a healthcare professional before using dequalinium chloride, although systemic absorption from topical use is considered minimal.
- The product should be kept out of reach of children to prevent accidental ingestion or choking, especially with lozenge formulations.
- This medication is not a substitute for systemic antibiotic therapy when a systemic infection is present.
How it Works (Mechanism of Action)
Dequalinium chloride is a quaternary ammonium compound that functions as a broad-spectrum antiseptic with bactericidal and fungicidal properties. Its mechanism of action primarily involves its cationic surfactant nature. As a positively charged molecule, it is strongly attracted to and readily binds with the negatively charged components of microbial cell membranes, including those of bacteria and fungi. This binding process leads to a significant disruption of the cell membrane's integrity and permeability. The compromised membrane allows for the rapid leakage of essential intracellular components, such as nucleic acids, proteins, amino acids, and ions, from the microbial cell into the extracellular environment. This loss of vital cellular constituents and the subsequent metabolic disarray ultimately lead to bacterial and fungal cell death. Dequalinium chloride exhibits activity against a wide range of Gram-positive bacteria (e.g., Streptococcus spp., Staphylococcus spp.), some Gram-negative bacteria, and several pathogenic fungi, particularly Candida albicans, which is a common cause of oral candidiasis. Its action is local and superficial, primarily affecting microorganisms residing on the mucosal surfaces of the oral cavity and pharynx, with negligible systemic absorption.
Commercial Brands (Alternatives)
No other brands found for this formula.